U.S. Markets open in 3 hrs 28 mins
  • S&P Futures

    4,239.50
    +3.25 (+0.08%)
     
  • Dow Futures

    33,899.00
    +64.00 (+0.19%)
     
  • Nasdaq Futures

    14,271.00
    +12.75 (+0.09%)
     
  • Russell 2000 Futures

    2,292.00
    -0.50 (-0.02%)
     
  • Crude Oil

    73.45
    +0.60 (+0.82%)
     
  • Gold

    1,782.70
    +5.30 (+0.30%)
     
  • Silver

    26.01
    +0.16 (+0.61%)
     
  • EUR/USD

    1.1945
    +0.0001 (+0.0119%)
     
  • 10-Yr Bond

    1.4720
    0.0000 (0.00%)
     
  • Vix

    16.45
    -1.44 (-8.05%)
     
  • GBP/USD

    1.3961
    +0.0014 (+0.1019%)
     
  • USD/JPY

    110.9700
    +0.3350 (+0.3028%)
     
  • BTC-USD

    33,968.78
    +2,319.52 (+7.33%)
     
  • CMC Crypto 200

    812.49
    +18.17 (+2.29%)
     
  • FTSE 100

    7,102.07
    +12.06 (+0.17%)
     
  • Nikkei 225

    28,874.89
    -9.24 (-0.03%)
     

Medifast, In A Buy Zone, Shows Rising RS Rating

·1 min read
Medifast, In A Buy Zone, Shows Rising RS Rating
  • Oops!
    Something went wrong.
    Please try again later.

Medifast had its Relative Strength (RS) Rating upgraded from 89 to 93 Tuesday. The IBD 50 stock is still inside a buy zone after clearing a 279.56 buy point in a consolidation. Once a stock moves 5% or higher beyond the initial entry, it's considered out of a proper buying area.